Advertisement

ADVERTISEMENT

Acute Ischemic Stroke

Neal S. Parikh, MD, on Smoking Rates Among Survivors of Acute Ischemic Stroke
Podcasts
Neal S. Parikh, MD, on Smoking Rates Among Survivors of Acute Ischemic Stroke
10/01/2020
In this podcast, Dr Parikh discusses the findings of his recent study, which indicated that, smoking rates have not decreased over the past 2 decades among survivors of acute ischemic stroke, unlike the general population. He also reviews...
In this podcast, Dr Parikh discusses the findings of his recent study, which indicated that, smoking rates have not decreased over the past 2 decades among survivors of acute ischemic stroke, unlike the general population. He also reviews...
In this podcast, Dr Parikh...
10/01/2020
Neurology
Shumei Man, MD, PhD, on Shortening Door-to-Needle Times in Acute Ischemic Stroke
Podcasts
Shumei Man, MD, PhD, on Shortening Door-to-Needle Times in Acute Ischemic Stroke
08/11/2020
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare...
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare...
In this podcast, Dr Man...
08/11/2020
Neurology
News
Acute Ischemic Stroke: Shorter Thrombolytic Door-to-Needle Time Tied to Better 1-Year Outcomes
06/03/2020
Researchers investigated whether shorter door-to-needle times were associated with improved long-term outcomes among more than 61,000 Medicare beneficiaries aged 65 years or older who were treated for acute ischemic stroke.
Researchers investigated whether shorter door-to-needle times were associated with improved long-term outcomes among more than 61,000 Medicare beneficiaries aged 65 years or older who were treated for acute ischemic stroke.
Researchers investigated whether...
06/03/2020
Neurology
News
5 Questions on the Optimization of Patient Selection for Endovascular Therapy in AIS
04/07/2020
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in...
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in...
Neurology Consultant spoke with...
04/07/2020
Neurology
Review
Intracranial Stent-assisted Revascularization for Acute Ischemic Stroke
11/07/2009

Hopkins, Levy, Siddiqui, Karmon, Natarajan

Hopkins, Levy, Siddiqui, Karmon, Nata...
In this article, we provide a snapshot of the strengths and limitations of current FDA-approved stroke therapies and discuss the rationale, technique, outcomes, limitations, and future of stent-assisted recanalization.
In this article, we provide a snapshot of the strengths and limitations of current FDA-approved stroke therapies and discuss the rationale, technique, outcomes, limitations, and future of stent-assisted recanalization.
In this article, we provide a...
11/07/2009
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use